Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis

• related:
• tags: #literature
• links: PDF, source

---

Persistent Notes

Highlights

Reference

Chalmers JD, Haworth CS, Metersky ML, et al. Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. N Engl J Med. 2020;383(22):2127-2137. doi:10.1056/NEJMoa2021713

Links to this note

• chronic bronchiectasis

  • Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis

• Major pulmonary studies to know

  • [^1]: Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis [^3]: Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

• use of brensocatib reduces exacerbation in bronchiectasis

  • [^1]: Bronchiectasis Lecture by Jennifer Krall?